Great news for people living with type 1 diabetes (T1D) in Australia — Omnipod® 5 is now officially compatible with the FreeStyle Libre® 2 Plus sensor. This long-awaited integration marks a significant milestone in diabetes technology, offering more freedom, flexibility, and personalised care than ever before.
Until now, Australians using Omnipod 5 — the world’s first tubeless automated insulin delivery (AID) system — were limited to using Dexcom G6 or G7 continuous glucose monitoring (CGM) sensors. With this update, users can now also choose FreeStyle Libre 2 Plus, giving them more control over how they manage their condition.
Why This Matters
Living with type 1 diabetes means constantly making decisions — what to eat, when to dose insulin, how to respond to activity, and much more. That’s why choice matters.
More flexibility: Families with children living with T1D can select the solution that provides the easiest and most effective care. Whether it’s the longer wear time of the Libre sensor or the predictive alerts of Dexcom, the choice is now in their hands.
More empowerment: Technology should work for the person — not the other way around. This new compatibility empowers Australians to customise their diabetes management plan around their lives, not the limitations of devices.
What Is the FreeStyle Libre 2 Plus?
The FreeStyle Libre 2 Plus sensor is Abbott’s next-generation CGM system. Unlike the standard Libre 2, the Plus version offers enhanced connectivity and real-time data sharing, making it suitable for closed-loop systems like Omnipod 5. With 15-day wear, optional high and low glucose alarms, and no routine finger pricks, it's a favourite among many users globally. Finger pricks are required if glucose readings and symptoms do not match or during rapid glucose changes.
What Is Omnipod 5?
Omnipod 5 is an automated insulin delivery system that works with a compatible CGM to predict and adjust insulin delivery every five minutes. It's tubeless, waterproof, and can be managed via smartphone or controller. Users gain tighter glucose control without constant manual input — a game changer for many.
Why Australia Is Excited
Australia has long been a leader in diabetes care and technology adoption. But until now, Australians were missing the Libre compatibility that some other countries already had. This integration fills that gap and brings Australia in line with the global movement toward interoperable diabetes tech.
It also represents a collaborative success between Insulet (the maker of Omnipod) and Abbott (the maker of the Libre system), both of which have strong footprints in Australia’s healthcare landscape.
What’s Next?
This compatibility is just the beginning. As diabetes tech continues to evolve, more integrations, features, and personalised options are expected to follow. Whether you're newly diagnosed or a tech-savvy veteran of diabetes management, this development opens new doors.
Final Thoughts
Diabetes is personal. It affects everyone differently — and so should the tools we use to manage it. The integration of FreeStyle Libre 2 Plus with Omnipod 5 means more freedom, more confidence, and better care for thousands of Australians. For more news like this visit diabetesABC.com
